Mirum Pharmaceuticals Inc (MIRM)
41.50
+0.37
(+0.90%)
USD |
NASDAQ |
Dec 20, 16:00
41.49
-0.01
(-0.02%)
After-Hours: 20:00
Mirum Pharmaceuticals Shareholders Equity (Quarterly): 232.02M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 156.64M |
| Cytokinetics Inc | -13.91M |
| Amicus Therapeutics Inc | 178.82M |
| Ocugen Inc | 40.63M |
| Scholar Rock Holding Corp | 79.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 667.89M |
| Total Liabilities (Quarterly) | 435.87M |
| Debt to Equity Ratio | 1.326 |
| Current Ratio | 3.340 |
| Net Debt Paydown Yield | -0.02% |